Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1868-6982|23|9|523-532

ISSN： 1868-6974

Source： JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.23, Iss.9, 2016-09, pp. : 523-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients

By  

Pancreatology, Vol. 1, Iss. 5, 2001-09 ,pp. : 486-509

Karger

Access to resources Recommend Favorite

Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma

By  

Pancreatology, Vol. 7, Iss. 5-6, 2007-10 ,pp. : 459-469

Karger

Access to resources Recommend Favorite

Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma

By  

Pancreatology, Vol. 11, Iss. 3, 2011-07 ,pp. : 343-350

Karger

Access to resources Recommend Favorite

Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies

By  

HISTOPATHOLOGY, Vol. 66, Iss. 3, 2015-02 ,pp. : 457-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1392-1404

John Wiley & Sons Inc

Access to resources Recommend Favorite